Arcturus Therapeutics Holdings Inc. ( ARCT) - Key Metrics
ARCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | -$0.14 | -$1.06 | -$0.59 | -$0.60 |
| 2025Q3 | $0.63 | -$0.49 | -$0.63 | -$0.64 |
| 2025Q2 | $0.90 | -$0.34 | -$0.21 | -$0.21 |
| 2025Q1 | $1.08 | -$0.52 | -$1.30 | -$1.30 |
ARCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.44 |
| 2025Q3 | ? | -9.32 |
| 2025Q2 | ? | -9.61 |
| 2025Q1 | ? | -5.10 |
ARCT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -8.86% | ? |
| 2025Q4 | -9.75% | ? |
| 2025Q3 | -3.46% | ? |
| 2025Q2 | -1.63% | ? |
| 2025Q1 | -12.29% | ? |
ARCT
Price: $7.14
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 359653
Ebitda: -2.9 millionMarket Capitalization: 217.4 million